A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline
Clinical trial NCT05199142 · TERMINATED
Trial details
- NCT number
- NCT05199142
- Sponsor
- Syndesi Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2022-03-11
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.